When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
RYTM - Rhythm Pharma inks distribution deal for Imcivree in Israel
Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals (RYTM) and Medison Pharma announce an exclusive distribution agreement for Medison to commercialize Rhythm’s melanocortin-4 (MC4) receptor agonist Imcivree (setmelanotide) in Israel. Imcivree was approved in November 2020 by the FDA for chronic weight management in adults and pediatric patients 6 years of age and older with obesity due to proopiomelanocortin, proprotein convertase subtilisin/kexin type 1 or leptin receptor deficiency confirmed by genetic testing.